THE EFFICACY AND SAFETY OF 12-WEEK SOF/VEL REGIMEN COMBINED WITH PROPHYLACTIC USE OF TAF FOR TREATMENT-NAIVE genotype1-6 HCV/HBV CO-INFECTION ADULT PATIENTS WITH OR WITHOUT COMPENSATED CIRRHOSIS IN CHINA: A MULTI-CENTER PROSPECTIVE, SINGLE-ARM, OPENLABEL TRIAL
HEPATOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined